Project Grant 20253941045526
- Federal Grant Award Summary Obeewan Technologies Inc. received a $305,000 Project Grant from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), with an award date of June 1, 2025 and completion date of May 31, 2026. The company is developing a bio-acoustic technology system designed to locate queen honey bees within managed hives by mimicking naturally occurring queen bee piping sounds to trigger predictable behavioral responses. This...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $718,938 project grant from the USDA National Institute of Food and Agriculture under the Agriculture and Food Research Initiative (AFRI) program (CFDA 10.310), effective December 15, 2025, through December 14, 2028. The project addresses unsustainable losses in managed honey bee colonies by developing novel anti-Varroa mite technologies that inhibit mite feeding and pathogen transmission....
- Federal Grant Award Summary Giner, Inc. received a $181,429 Project Grant from the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) under the Small Business Innovation Research (SBIR) Program (CFDA 10.212), awarded on September 15, 2025, with a completion date of May 14, 2026. The company is developing a bacteriophage-based topical treatment to combat bovine mastitis, a bacterial infection affecting approximately 30% of dairy cattle during milking periods. The...
- The Bee Informed Partnership, Inc. will receive a $142,676 cooperative agreement award from the United States Department of Agriculture Animal and Plant Health Inspection Service under the Plant and Animal Disease, Pest Control, and Animal Care federal grant program (CFDA 10.025). Through this funding, the Bee Informed Partnership will determine the composition, diversity, and recombination rates of deformed wing virus variants in honey bee and Varroa mite populations across U.S. commercial...
- Federal Grant Award Summary Texas A&M Agrilife Research received a $1.0 million Project Grant from the USDA National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI) program (CFDA 10.310), awarded January 1, 2026, with completion targeted for December 31, 2030. The project addresses critical challenges in honey bee reproductive health and colony sustainability by conducting integrated research examining how environmental factors affect...
- Federal Grant Award Summary Cornell University's Office of Sponsored Programs received a $224,710 project grant award from the U.S. Department of Agriculture's Institute of Food Production and Sustainability under the Agriculture and Food Research Initiative (AFRI) (CFDA 10.310) on February 1, 2026, with completion anticipated by January 31, 2028. The research project, conducted in Ithaca, New York, addresses the intersection of fungicide exposure and antibiotic efficacy in honeybee disease...
- The National Science Foundation awarded a $255,262 Small Business Technology Transfer Phase I Project Grant to IF, LLC of Stoughton, WI for the period of January 15, 2022 through December 31, 2022. The grant supports the development of an Automated Continuous Varroa Mite Monitor for Honeybee Hive Health under the NSF Engineering program (CFDA 47.041). The Engineering program seeks to improve quality of life and economic strength through fostering innovation in engineering research and education....
- Federal Grant Award Summary Mississippi State University received a $591,500 Project Grant from the USDA National Institute of Food and Agriculture under the Agriculture and Food Research Initiative (AFRI) Program (CFDA 10.310), effective March 1, 2026, through February 28, 2029. The award supports the development and testing of a portable, cost-effective radar tracking system to monitor individual honeybee foraging behavior in real agricultural landscapes. The system pairs a commercial radar...
- Federal Grant Award Summary Beesafe Labs, LLC received a $305,000 Small Business Innovation Research (SBIR) Phase I grant from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) for the period of October 1, 2025 through September 30, 2026. The project, performed in San Diego, California, focuses on developing defensive artificial intelligence technology in the form of honeypot Large Language Model (LLM) chatbots designed to...
- Federal Project Grant Award Summary Luna Labs USA LLC received a $175,000 Phase I Project Grant award dated September 30, 2025, from the National Institute of Food and Agriculture (NIFA) under the Small Business Innovation Research (SBIR) Program and Small Business Technology Transfer (STTR) Program (CFDA 10.212) to develop a droplet-based diagnostic device for detecting microRNAs (miRNAs) associated with Barley Yellow Dwarf Virus (BYDV) infection in cereal crops. The project, performing in...
Elixide LLC received a $180,947 Phase I Project Grant from the U.S. Department of Agriculture's National Institute of Food and Agriculture under the Small Business Innovation Research (SBIR) Program (CFDA 10.212), awarded September 30, 2025, with a completion date of May 31, 2027. The project addresses critical losses in domestic honey bee colonies, which reached 48% in 2023—significantly exceeding the historical average of 39.6% since 2010. Deformed wing virus (DWV), an RNA virus, is identified as a primary driver of honey bee mortality, creating a $250 million annual economic burden for commercial beekeepers and threatening food safety and ecosystem stability. Under Phase I, Elixide will develop broad-spectrum antiviral therapeutics targeting RNA-dependent RNA polymerase (RdRP), the viral replication mechanism absent in honey bees and mammals, making it a safe therapeutic target. The company will leverage advanced computational modeling—including ColabFold and machine learning approaches derived from AlphaFold—combined with two independent drug discovery platforms (SilcsBio and OpenVS with RosettaVS protocol) to identify RdRP inhibitors for DWV. Safety and efficacy testing will be conducted on honey bees, with Phase II development planned to optimize drug-like properties and demonstrate colony-level effectiveness. The projected honey bee medicine market of $135 million domestically and $5 billion globally positions this innovation with significant commercial potential across veterinary and agricultural applications.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 3/10/26 | ||
| Not listed | $180.9k | 9/26/25 |